REPREXAIN Drug Patent Profile
✉ Email this page to a colleague
When do Reprexain patents expire, and what generic alternatives are available?
Reprexain is a drug marketed by Amneal Pharms Ny and is included in one NDA.
The generic ingredient in REPREXAIN is hydrocodone bitartrate; ibuprofen. There are twenty-three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate; ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Reprexain
A generic version of REPREXAIN was approved as hydrocodone bitartrate; ibuprofen by ACTAVIS LABS FL INC on December 31st, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for REPREXAIN?
- What are the global sales for REPREXAIN?
- What is Average Wholesale Price for REPREXAIN?
Summary for REPREXAIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Patent Applications: | 193 |
| DailyMed Link: | REPREXAIN at DailyMed |
Pharmacology for REPREXAIN
| Drug Class | Nonsteroidal Anti-inflammatory Drug Opioid Agonist |
| Mechanism of Action | Cyclooxygenase Inhibitors Opioid Agonists |
US Patents and Regulatory Information for REPREXAIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms Ny | REPREXAIN | hydrocodone bitartrate; ibuprofen | TABLET;ORAL | 076642-003 | Oct 19, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amneal Pharms Ny | REPREXAIN | hydrocodone bitartrate; ibuprofen | TABLET;ORAL | 076642-004 | Oct 19, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
